Clinical trial
Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder
NCT00211744 · Montefiore Medical Center, Other · Completed
Key facts
| NCT number | NCT00211744 |
|---|---|
| Title | Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder |
| Official title | Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder |
| Lead sponsor | Montefiore Medical Center, Other |
| Collaborators | Ortho-McNeil Pharmaceutical Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Obsessive-compulsive Disorder |
| Intervention type | Drug |
| Interventions | topiramate |
| Enrollment | 24 |
| Start date | Aug 1, 2004 |
| Completion | Aug 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | May 30, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: